Skip to main content

Ampio Pharmaceuticals, Inc.

AMPEDelisted Apr 4, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001411906

Ampio Pharmaceuticals, Inc. was delisted on Apr 4, 2024; its insiders filed their last Form 4 on Jun 13, 2023; 28 institutions reported holding it in 13F filings for Q1 2024, worth $34.2K in total; no superinvestor held it.

Q3 2023 vs. Q2 2023

How the institutions holding Ampio Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of AMPE: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders3526−9
SharesConverted for a 1-for-20 split21.3K2.35K−18.9K (−89.0%)
Value$98.8K$8.44K−$90.4K (−91.5%)

New holders (3)

Institutions that held Ampio Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to AMPE in Q3 2023
InstitutionSharesValue% of portfolio
Tower Research Capital LLC (TRC)114$4150.00%
Stonebridge Capital Advisors LLC4$150.00%
FMR LLC2$70.00%

Sold out (12)

Institutions that held Ampio Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of AMPE in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
HRT Financial LP104,040$24.0K
CVA Family Office, LLC73,567$17.1K
Two Sigma Securities, LLC30,144$7.02K
Renaissance Technologies LLC28,500$7.00K
Virtu Financial LLC25,291$6.00K
Brighton Jones LLC24,603$5.73K
Western Wealth Management, LLC24,471$5.70K
IHT Wealth Management, LLC23,937$5.58K
Courier Capital LLC21,943$5.11K
Raymond James Financial Services Advisors, Inc.10,723$2.50K
Advisory Resource Group10,000$2.33K
Delta Financial Group, Inc.10,700$2.00K